1Jeffrey S. Berger,Maria C. Roncaglioni,Fausto Avanzini,Ierta Pangrazzi,Gianni Tognoni,David L. Brown,崔艳丽（译）,赵秀丽（校）.阿斯匹林在男性和女性心血管事件一级预防中的应用——随机对照试验性别特异性汇总分析[J].美国医学会杂志（中文版）,2006,25(5):275-282. 被引量：40
2Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China : twenty-one-year observational study from the Sino- MONICA-Beijing Project. Stroke,2008,39 : 1668-1674.
3Algra A, Van Gijn J, Algra A, et al. Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry, 1999,66:557-559.
4Sacco M, Pellegrini F, Roncaglioni MC, et al. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care,2003,26:3264-3272.
5Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci, 1996,143 : 1-13.
6Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemie attacks. Neurology, 1997,48:524- 525.
7Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atheroselerosis. Stroke, 2003,34:2361-2366.
8A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996,348 : 1329-1339.
9Ringleb PA, Bhatt DL, Hirsch AT, et al. Benefit of elopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke,2004,35:528-532.
10Bhatt DL, Marso SP, Hirsch AT, et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol,2002,90:625-628.
7Zou Y,Zhu Q, Deng Y,et al. Vascular risk factors and mild cognitiveimpairment in the elderly population in Southwest China [ J ]. Am JAlzheimers Dis Other Demen, 2014,29(3) :242 -247.
8Jolly SS,Yusuf S,Caims J,et al. Radial versus femoral access for cor-onary angiography and intervention in patients with acute coronary syn-dromes (RIVAL) ; a randomized, parallel group, multicenter trail[ J].Lancet, 2011,377:1409-1410.
9Gunasekaran S,Cherukupalli R. Radial artery perforation and its man-agement during PCI[ J]. J Invasive Cardiol, 2009 ,21 (2) :E24 -26.
10Li J1,Song M,Jian Z,et al.Laboratory aspirin resistance and the risk of major adverse cardiovascular events in patients with cor- onary heart disease on confirmed aspirin adherence[J].J Atheroscler Thromb,2014,21 (3):239-247.
